Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02866747
Title A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma (STERIMGLI)
Acronym STERIMGLI
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Institut Claudius Regaud
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Institut de Cancerologie de L'Ouest Angers 49055 France Details
Hopital Avicenne Bobigny 93 000 France Details
Centre Francois Baclesse Caen 14 000 France Details
Centre Georges Francois Leclerc Dijon 21 000 France Details
Institut Regional Du Cancer de Montpellier Montpellier 34 298 France Details
Hopital Pitie Salpetriere Paris 75013 France Details
Institut Curie Saint Cloud 92 210 France Details
Centre Paul Strauss Strasbourg 67000 France Details
Institut Claudius Regaud Toulouse France Details
Institut Gustave Roussy Villejuif 94 800 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field